KDNY - Chinook Therapeutics GAAP EPS of -$0.83 misses by $0.20 revenue of $2.5M beats by $2.38M November, 10 2022 05:14 PM Chinook Therapeutics Inc Com Chinook Therapeutics press release ( NASDAQ: KDNY ): Q3 GAAP EPS of -$0.83 misses by $0.20 . Revenue of $2.5M beats by $2.38M . For further details see: Chinook Therapeutics GAAP EPS of -$0.83 misses by $0.20, revenue of $2.5M beats by $2.38M